Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Anticancer effects of imatinib via immunostimulation

Nature Medicine volume 17, pages 1050–1051 (2011)Cite this article

Subjects

Imatinib represents the quintessential example of a targeted anticancer agent that directly suppresses the activation of oncogenic tyrosine kinases. Surprisingly, in the context of gastrointestinal stromal tumors (GISTs), the therapeutic effect of imatinib crucially depends on the reactivation of an anticancer immune response (pages 1094–1100).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Putative scenarios in imatinib-treated GIST.

Katie Vicari

References

  1. Hanahan, D. & Weinberg, R.A. Cell 144, 646–674 (2011).

    Article  CAS  PubMed  Google Scholar 

  2. Pierotti, M.A., Tamborini, E., Negri, T., Pricl, S. & Pilotti, S. Nat. Rev. Clin. Oncol. 8, 161–170 (2011).

    Article  CAS  PubMed  Google Scholar 

  3. Balachandran, V.P. et al. Nat. Med. 17, 1094–1100 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Taieb, J. et al. Nat. Med. 12, 214–219 (2006).

    Article  CAS  PubMed  Google Scholar 

  5. Borg, C. et al. J. Clin. Invest. 114, 379–388 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Delahaye, N.F. et al. Nat. Med. 17, 700–707 (2011).

    Article  CAS  PubMed  Google Scholar 

  7. Ghiringhelli, F. et al. J. Exp. Med. 202, 1075–1085 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Okada, M. et al. Blood 103, 2299–2307 (2004).

    Article  CAS  PubMed  Google Scholar 

  9. Zitvogel, L., Kepp, O. & Kroemer, G. Cell 140, 798–804 (2010).

    Article  CAS  PubMed  Google Scholar 

  10. Mohty, M. et al. Blood 103, 4666–4668 (2004).

    Article  CAS  PubMed  Google Scholar 

  11. Catellani, S., Pierri, I., Gobbi, M., Poggi, A. & Zocchi, M.R. PLoS ONE 6, e18925 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Preudhomme, C. et al. N. Engl. J. Med. 363, 2511–2521 (2010).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laurence Zitvogel is at the Institut Gustave Roussy (IGR), Villejuif, France; the Center of Clinical Investigations, IGR, Villejuif, France; and the University of Paris Sud, Villejuif, France.,

    Laurence Zitvogel

  2. the Institut National de la Santé et de la Recherche Médicale (INSERM) U1015, IGR, Villejuif, France,

    Laurence Zitvogel

  3. Guido Kroemer is at INSERM U848, Villejuif, France; the Centre de Recherche des Cordeliers, Paris, France; the Pôle de Biologie, Hôpital Européen Georges Pompidou, Paris, France; and the Université Paris Descartes, Sorbonne Paris Cité Faculté de Médecine, Paris, France.,

    Guido Kroemer

  4. the Metabolomics Platform, IGR, Villejuif, France,

    Guido Kroemer

Authors
  1. Laurence Zitvogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guido Kroemer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Laurence Zitvogel or Guido Kroemer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zitvogel, L., Kroemer, G. Anticancer effects of imatinib via immunostimulation. Nat Med 17, 1050–1051 (2011). https://doi.org/10.1038/nm.2429

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2429

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer